Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Whole Exome Sequencing and Extended Thrombophilia Testing in Patients with Venous Thromboembolism

Blood (2018) 132 (Supplement 1): 2506.

https://doi.org/10.1182/blood-2018-99-115529

Published: 2018

Journal Articles

The Use of Oral Anticoagulants for the Treatment of Venous Thromboembolism in Cancer Patients

Christine Cambareri, PharmD, BCPS, Xiaopan Yao, PhD, Man Yee Merl, PharmD, BCOP, Trinh Pham, PharmD, BCOP, Alfred I Lee, MD PhD

Blood (2015) 126 (23): 4728.

https://doi.org/10.1182/blood.V126.23.4728.4728

Published: 2015

Journal Articles

Whole Exome Sequencing in Evaluation of Thrombophilia: A Novel 33-Gene Panel

Eun-Ju Lee, MD, Daniel Dykas, BS, Allen Bale, MD, Caroline Cromwell, MD, Terri L Parker, MD, Stephanie Halene, MD, PhD, Adrienne Burns, PA, Xiaopan Yao, PhD, Alfred I Lee, MD PhD

Blood (2015) 126 (23): 3529.

https://doi.org/10.1182/blood.V126.23.3529.3529

Published: 2015

Journal Articles

Fluzone® High-Dose Influenza Vaccine with a Booster Is Associated with Low Rates of Influenza Infection in Patients with Plasma Cell Disorders

Andrew R Branagan, MD, Eamon Duffy, Chandra Sekhar Boddupall, PhD, Randy A Albrecht, PhD, Lin Zhang, Rakesh Verma, PhD, Dennis L Cooper, MD, Stuart Seropian, MD, Terri L Parker, MD, Xiaopan Yao, PhD, Thomas M Ferencz, RPh, Madhav V Dhodapkar, MD

Blood (2015) 126 (23): 3058.

https://doi.org/10.1182/blood.V126.23.3058.3058

Published: 2015

Journal Articles

Clinical and pharmacodynamic analysis of pomalidomide dosing strategies in myeloma: impact of immune activation and cereblon targets

Kartik Sehgal, Rituparna Das, Lin Zhang, Rakesh Verma, Yanhong Deng, Mehmet Kocoglu, Juan Vasquez, Srinivas Koduru, Yan Ren, Maria Wang, Suzana Couto, Mike Breider, Donna Hansel, Stuart Seropian, Dennis Cooper, Anjan Thakurta, Xiaopan Yao, Kavita M. Dhodapkar, Madhav V. Dhodapkar

Blood (2015) 125 (26): 4042–4051.

https://doi.org/10.1182/blood-2014-11-611426

Published: 2015

Includes: Supplemental data

Journal Articles

Using the Rothman Index to Predict Discharge and Readmission Rates in an Inpatient Hematology Unit

Roger Y. Kim, BS, Xiaopan Yao, PhD, Peter Longley, RN, DNP, Joan Rimar, DNSc, RN, Chryssanthi Kournioti, MD, Alfred Ian Lee, MD PhD

Blood (2014) 124 (21): 1302.

https://doi.org/10.1182/blood.V124.21.1302.1302

Published: 2014

Journal Articles

Comparison Of Intermittent and Continuous Dosing Regimens Of Pomalidomide In Relapsed/Refractory Myeloma: Results Of A Phase II Randomized Trial

Kartik Sehgal, MBBS, Mehmet H. Kocoglu, MD, Yanhong Deng, Rakesh Verma, Ph.D, Lin Zhang, Dennis L. Cooper, MD, Xiaopan Yao, Kavita Dhodapkar, MD, Madhav V. Dhodapkar, MD

Blood (2013) 122 (21): 3205.

https://doi.org/10.1182/blood.V122.21.3205.3205

Published: 2013

Journal Articles

Post-Transplantation Lymphoproliferative Disorders (PTLD) Management in Solid Organ Transplantation (SOT) Recipients

Nikolai A. Podoltsev, MD, PhD, Ivan Bustillo, MD, Xiaopan Yao, PhD, Haibei Liu, Dennis L. Cooper, MD

Blood (2011) 118 (21): 4941.

https://doi.org/10.1182/blood.V118.21.4941.4941

Published: 2011

Journal Articles

Lenalidomide and prednisone for myelofibrosis: Eastern Cooperative Oncology Group (ECOG) phase 2 trial E4903

Ruben A. Mesa, Xiaopan Yao, Larry D. Cripe, Chin Yang Li, Mark Litzow, Elisabeth Paietta, Jacob M. Rowe, Ayalew Tefferi, Martin S. Tallman

Blood (2010) 116 (22): 4436–4438.

https://doi.org/10.1182/blood-2010-05-287417

Published: 2010

Journal Articles

Tipifarnib Is Well Tolerated as Maintenance Therapy In Acute Myeloid Leukemia (AML). Significant, but Non-Fatal, Hematologic Toxicity Not Ameliorated by Dose Reduction. Preliminary Results of the Phase III Intergroup Trial E2902

Selina Luger, MD, Xiaopan Yao, PhD, MS, Elisabeth Paietta, PhD, Rhett Ketterling, Witold Rybka, MD, Mark R. Litzow, MD, Jacob M. Rowe, Richard Larson, M.D., Martin S. Tallman, MD

Blood (2010) 116 (21): 3315.

https://doi.org/10.1182/blood.V116.21.3315.3315

Published: 2010

Journal Articles

Predictive Factors for All-Trans Retinoic Acid Related Differentiation Syndrome In Acute Promyelocytic Leukemia.

Houry Leblebjian, Pharm.D., Anne McDonnell, Pharm.D., BCOP, J. Andrew Skirvin, Pharm.D., BCOP, Martha Wadleigh, MD, Xiaopan Yao, PhD, MS, Donna Neuberg, ScD, Sylvia Bartel, R.Ph., M.H.P., Daniel J DeAngelo, MD, PhD, Richard M Stone, M.D.

Blood (2010) 116 (21): 1052.

https://doi.org/10.1182/blood.V116.21.1052.1052

Published: 2010

Journal Articles

Results of a Prospective Multicenter Phase II Study of Initial Treatment with Methotrexate In LGL Leukemia (ECOG Protocol E5998)

Thomas P. Loughran, Jr., MD, Xiaopan Yao, PhD, MS, John M. Bennett, MD, Mark R. Litzow, MD, Andrew M Evens, DO, MSc, Martin S. Tallman, MD

Blood (2010) 116 (21): 702.

https://doi.org/10.1182/blood.V116.21.702.702

Published: 2010

Journal Articles

WT1 mutations in T-ALL

Blood (2009) 114 (5): 1038–1045.

https://doi.org/10.1182/blood-2008-12-192039

Published: 2009

Includes: Supplemental data

Journal Articles

The Pitfalls of Early Publication of Data in Acute Myeloid Leukemia: A Report from the Eastern Cooperative Oncology Group (ECOG).

Jacob M. Rowe, MD, Xiaopan Yao, Ph.D, Peter A. Cassileth, MD, Frederick R. Appelbaum, MD, Peter H. Wiernik, MD, Charles Schiffer, MD, Mark R. Litzow, MD, Selina Luger, MD, John M. Bennett, MD, Hillard M Lazarus, MD, Martin S Tallman

Blood (2008) 112 (11): 1952.

https://doi.org/10.1182/blood.V112.11.1952.1952

Published: 2008

Journal Articles

Lenalidomide and Prednisone for Primary and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis (MF): An Eastern Cooperative Oncology Group (ECOG) Phase II Trial.

Ruben A. Mesa, MD, FACP, Xiaopan Yao, Larry D. Cripe, MD, Chin Yang Li, MD, Ayalew Tefferi, MD, Martin S. Tallman, MD

Blood (2008) 112 (11): 1753.

https://doi.org/10.1182/blood.V112.11.1753.1753

Published: 2008

NARROW

Whole Exome Sequencing and Extended Thrombophilia Testing in Patients with Venous Thromboembolism

The Use of Oral Anticoagulants for the Treatment of Venous Thromboembolism in Cancer Patients

Whole Exome Sequencing in Evaluation of Thrombophilia: A Novel 33-Gene Panel

Fluzone® High-Dose Influenza Vaccine with a Booster Is Associated with Low Rates of Influenza Infection in Patients with Plasma Cell Disorders

Clinical and pharmacodynamic analysis of pomalidomide dosing strategies in myeloma: impact of immune activation and cereblon targets

Using the Rothman Index to Predict Discharge and Readmission Rates in an Inpatient Hematology Unit

Comparison Of Intermittent and Continuous Dosing Regimens Of Pomalidomide In Relapsed/Refractory Myeloma: Results Of A Phase II Randomized Trial

Post-Transplantation Lymphoproliferative Disorders (PTLD) Management in Solid Organ Transplantation (SOT) Recipients

Lenalidomide and prednisone for myelofibrosis: Eastern Cooperative Oncology Group (ECOG) phase 2 trial E4903

Tipifarnib Is Well Tolerated as Maintenance Therapy In Acute Myeloid Leukemia (AML). Significant, but Non-Fatal, Hematologic Toxicity Not Ameliorated by Dose Reduction. Preliminary Results of the Phase III Intergroup Trial E2902

Predictive Factors for All-Trans Retinoic Acid Related Differentiation Syndrome In Acute Promyelocytic Leukemia.

Results of a Prospective Multicenter Phase II Study of Initial Treatment with Methotrexate In LGL Leukemia (ECOG Protocol E5998)

WT1 mutations in T-ALL

The Pitfalls of Early Publication of Data in Acute Myeloid Leukemia: A Report from the Eastern Cooperative Oncology Group (ECOG).

Lenalidomide and Prednisone for Primary and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis (MF): An Eastern Cooperative Oncology Group (ECOG) Phase II Trial.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only